8-K - Aclaris Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Aclaris Therapeutics, Inc. filed an 8-K on March 9, 2026, with Items listed as N/A. The filing includes an Item 7.01 disclosure, which shall not be deemed 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to liability thereunder.

Key Takeaways

1Filing date: 2026-03-09

2Form type: 8-K

3Items: N/A

4Item 7.01 disclosure present

5Item 7.01 not deemed 'filed' under Section 18 of the Exchange Act

Current Report Details

Event Type

Regulation Fd

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the li

Regulation Fd

Exhibits (1)

8-K